author-photo

Peter C. Thuss-Patience

Charité

213

Papers

4159

Citations

Citation Trend

Filter By

Papers (213) Sort By

Journal Conference Others

1430P Frequency of PD-L1 positivity and microsatellite instability (MSI) in the DANTE trial: Perioperative atezolizumab with FLOT versus FLOT alone in patients with resectable esophagogastric adenocarcinoma. A randomized, open-label phase IIb trial of the German gastric group at the AIO and SAKK

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
1429P Pathological regression in patients with microsatellite instability (MSI) receiving perioperative atezolizumab in combination with FLOT vs. FLOT alone for resectable esophagogastric adenocarcinoma: Results from the DANTE trial of the German Gastric Group at the AIO and SAKK

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Inductive Preoperative Chemotherapy for Peritoneal Metastases of Tumors of the Upper GI Tract

2021
- Prisca Bartels
- Peter C. Thuss-Patience
Show All
- Source
- Cite
- Save
Citations (0)
Efficacy of Pembrolizumab Monotherapy for Advanced Gastric/Gastroesophageal Junction Cancer with Programmed Death Ligand 1 Combined Positive Score {greater than or equal to}10.

2021 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (12)
Trastuzumab in combination with 5-fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) as perioperative treatment for patients with HER2-positive locally advanced esophagogastric adenocarcinoma: A phase II trial of the AIO Gastric Cancer Study Group.

2021 International Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (3)
Pazopanib with 5-FU and oxaliplatin as first line therapy in advanced gastric cancer: A randomized phase-II study-The PaFLO trial. A study of the Arbeitsgemeinschaft Internistische Onkologie AIO-STO-0510.

2021 International Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Trifluridine/tipiracil in patients with metastatic gastroesophageal junction cancer: a subgroup analysis from the phase 3 TAGS study.

2021 Gastric Cancer
Show All
- Source
- Cite
- Save
Citations (1)
1376O The effect of hyperthermic intraperitoneal chemotherapy (HIPEC) upon cytoreductive surgery (CRS) in gastric cancer (GC) with synchronous peritoneal metastasis (PM): A randomized multicentre phase III trial (GASTRIPEC-I-trial)

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (1)
O-15 Randomized, phase 3 study of second-line tislelizumab vs chemotherapy in advanced or metastatic esophageal squamous cell carcinoma (RATIONALE 302) in the overall population and Europe/North America subgroup

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Systemic chemotherapy including ramucirumab in combination with pressurized intra-peritoneal aerosol chemotherapy (PIPAC) is a safe treatment option for peritoneal metastasis of gastric cancer

2021 Ejso
Show All
- Source
- Cite
- Save
Citations (0)